The Supervisory Board of the National Pharmaceutical Company Farmak made a resolution to open a Representative Office in Republic of Belarus.
The resolution to open a Representative Office of Farmak in Belarus was made in view of the necessity to develop markets and increase sales volumes of medicinal products in that country.
Farmak's Representative Office in the Republic of Belarus will carry out the functions of commodity market studies, market research; will represent and protect the interests of the company in government authorities and offices, commercial and non-commercial organizations.
Farmak's Representative Offices currently operate in Republic of Uzbekistan, Republic of Kazakhstan, Russian Federation and Kyrgyz Republic.
Farmak, as a member of the European Generic Medicines Association (EGA) – Medicines for Europe – and the Association of “Manufacturers of Drugs of Ukraine” (the AMDU), advocates for the creation of a coordination group at the Office of the President of Ukraine to prevent a shortage of medicines in Ukraine during the pandemic. […]
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]